SZSE:002898 (China)
Â
Class A
Â¥
11.20
(-1.06%)
Nov 29
Business Description
Sailong Pharmaceutical Group Co Ltd
ISIN : CNE1000032S5
Share Class Description:
SZSE:002898: Class ACompare
Compare
Traded in other countries / regions
002898.China IPO Date
2017-09-12Description
Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | 11.66 | |||||
| Interest Coverage | 2.59 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.33 | |||||
| Beneish M-Score | -2.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.1 | |||||
| 3-Year EPS without NRI Growth Rate | 70.5 | |||||
| 3-Year Book Growth Rate | -3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.96 | |||||
| 9-Day RSI | 52.41 | |||||
| 14-Day RSI | 54.06 | |||||
| 6-1 Month Momentum % | 8.25 | |||||
| 12-1 Month Momentum % | -28.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | |||||
| Quick Ratio | 0.75 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 179.57 | |||||
| Days Sales Outstanding | 65.59 | |||||
| Days Payable | 133.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.18 | |||||
| Dividend Payout Ratio | 0.91 | |||||
| Forward Dividend Yield % | 0.18 | |||||
| 5-Year Yield-on-Cost % | 0.18 | |||||
| Shareholder Yield % | -0.83 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.12 | |||||
| Operating Margin % | 5.75 | |||||
| Net Margin % | 0.5 | |||||
| FCF Margin % | -9.26 | |||||
| ROE % | 0.28 | |||||
| ROA % | 0.19 | |||||
| ROIC % | 0.45 | |||||
| ROC (Joel Greenblatt) % | 3.6 | |||||
| ROCE % | 2.59 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1244.44 | |||||
| PE Ratio without NRI | 509.09 | |||||
| Shiller PE Ratio | 65.88 | |||||
| PS Ratio | 6.51 | |||||
| PB Ratio | 3.73 | |||||
| Price-to-Tangible-Book | 4.83 | |||||
| Price-to-Operating-Cash-Flow | 1600.02 | |||||
| EV-to-EBIT | 138.34 | |||||
| EV-to-EBITDA | 138.34 | |||||
| EV-to-Revenue | 6.91 | |||||
| EV-to-FCF | -74.06 | |||||
| Price-to-Projected-FCF | 62.22 | |||||
| Price-to-Graham-Number | 10.47 | |||||
| Earnings Yield (Greenblatt) % | 0.72 | |||||
| FCF Yield % | -1.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sailong Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 303.993 | ||
| EPS (TTM) (Â¥) | 0.009 | ||
| Beta | 0.64 | ||
| Volatility % | 36.11 | ||
| 14-Day RSI | 54.06 | ||
| 14-Day ATR (Â¥) | 0.524743 | ||
| 20-Day SMA (Â¥) | 11.1735 | ||
| 12-1 Month Momentum % | -28.03 | ||
| 52-Week Range (Â¥) | 7.7 - 15.14 | ||
| Shares Outstanding (Mil) | 176 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sailong Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sailong Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sailong Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Sailong Pharmaceutical Group Co Ltd(SZSE:002898)'s stock price today?
The current price of SZSE:002898 is ¥11.20. The 52 week high of SZSE:002898 is ¥15.14 and 52 week low is ¥7.70.
When is next earnings date of Sailong Pharmaceutical Group Co Ltd(SZSE:002898)?
The next earnings date of Sailong Pharmaceutical Group Co Ltd(SZSE:002898) is .
Does Sailong Pharmaceutical Group Co Ltd(SZSE:002898) pay dividends? If so, how much?
The Dividend Yield %  of Sailong Pharmaceutical Group Co Ltd(SZSE:002898) is 0.18% (As of Today), Highest Dividend Payout Ratio of Sailong Pharmaceutical Group Co Ltd(SZSE:002898) was 2.22. The lowest was 0.31. And the median was 1.26. The  Forward Dividend Yield % of Sailong Pharmaceutical Group Co Ltd(SZSE:002898) is 0.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers